These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1608013)

  • 61. Blood transfusion: the high-risk life-saving therapy.
    Casey G
    Nurs N Z; 2011 May; 17(4):20-5. PubMed ID: 21736112
    [No Abstract]   [Full Text] [Related]  

  • 62. Current trends: evolving concepts in transfusion medicine. Leukoreduced blood components: "you can filter now or you can filter later.".
    Dzik WH
    Transfus Sci; 1992 Apr; 13(2):207-10. PubMed ID: 10148127
    [No Abstract]   [Full Text] [Related]  

  • 63. [Therapy with blood and blood components. 2. Perioperative management of hemostatic disturbances with blood components].
    Göddecke W; Götz E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 May; 33(5):321-33. PubMed ID: 9645292
    [No Abstract]   [Full Text] [Related]  

  • 64. Optimising strategies for the Spectra Optia.
    Morgan G
    Transfus Apher Sci; 2013 Dec; 49(3):688-91. PubMed ID: 24269748
    [No Abstract]   [Full Text] [Related]  

  • 65. Leukocyte-poor blood components: a purer and safer transfusion product for recipients?
    Rebulla P; Bertolini F; Parravicini A; Sirchia G
    Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):19-23. PubMed ID: 2134637
    [No Abstract]   [Full Text] [Related]  

  • 66. Statistical methods to the control of the production of blood components: principles and control charts for variables.
    Pereira P; Seghatchian J; Caldeira B; Xavier S; de Sousa G
    Transfus Apher Sci; 2018 Feb; 57(1):132-142. PubMed ID: 29526479
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blood Components for Pediatric Transfusions.
    Ozgonenel B; Nash TA; Rajpurkar M
    Pediatr Rev; 2020 May; 41(5):259-261. PubMed ID: 32358034
    [No Abstract]   [Full Text] [Related]  

  • 68. 2012 and beyond.
    Roberts DJ
    Transfus Med; 2012 Feb; 22(1):1-2. PubMed ID: 22332646
    [No Abstract]   [Full Text] [Related]  

  • 69. Future trends for provision of safer blood components/blood products.
    Allain JP
    Transfus Sci; 1996 Sep; 17(3):335. PubMed ID: 10163538
    [No Abstract]   [Full Text] [Related]  

  • 70. [Removal of serum-blocking activities using immobilized protein A columns].
    Sakita M; Imaki S; Hata K; Suzuki G; Takahashi T; Kinemura Y; Asakura K; Nomura T
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1334-40. PubMed ID: 3430024
    [No Abstract]   [Full Text] [Related]  

  • 71. Plasma Transfusions Prior to Central Line Placement in People with Abnormal Coagulation.
    Bidwell J
    Am J Nurs; 2017 Oct; 117(10):67. PubMed ID: 28957937
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Current methods of isolating blood components in relation to the experience of the blood transfusion center of the Central Scientific-Research Institute of Hematology and Blood Transfusion].
    Makarova EM; Demicheva MI; Egorov VM; Gurtovoĭ IM; Belorusova VA
    Gematol Transfuziol; 1986 Oct; 31(10):57-60. PubMed ID: 3792814
    [No Abstract]   [Full Text] [Related]  

  • 73. Leucocyte depletion of blood components.
    Bird A
    S Afr Med J; 2001 Oct; 91(10):822-3. PubMed ID: 11732450
    [No Abstract]   [Full Text] [Related]  

  • 74. [Method of determining protein-cellular microaggregates in hemotransfusion media and a device for its conduction].
    Timchenko NV; Petrov MM
    Gematol Transfuziol; 1985 Jul; 30(7):54-8. PubMed ID: 4054557
    [No Abstract]   [Full Text] [Related]  

  • 75. Practice guidelines for blood component therapy.
    Günter P
    Anesthesiology; 1996 Nov; 85(5):1219-20. PubMed ID: 8916854
    [No Abstract]   [Full Text] [Related]  

  • 76. Integrating the new generation of blood components into transfusion practice.
    Ness PM
    Transfusion; 1999 Sep; 39(9):1027-30. PubMed ID: 10533831
    [No Abstract]   [Full Text] [Related]  

  • 77. Strategies for elective red blood cell transfusion.
    Ross JM
    Ann Intern Med; 1992 Sep; 117(5):441; author reply 442. PubMed ID: 1503338
    [No Abstract]   [Full Text] [Related]  

  • 78. Applications of flow cytometry in transfusion medicine.
    Freedman J; Lazarus AH
    Transfus Med Rev; 1995 Apr; 9(2):87-109. PubMed ID: 7795335
    [No Abstract]   [Full Text] [Related]  

  • 79. Autografts of peripheral blood stem cells.
    Rist CL
    BMJ; 1994 Aug; 309(6951):411-2. PubMed ID: 8081169
    [No Abstract]   [Full Text] [Related]  

  • 80. Spotlights on "Process capability index trends": A new development in the manufacturing of blood components and related industries.
    Seghatchian J
    Transfus Apher Sci; 2021 Dec; 60(6):103315. PubMed ID: 34764018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.